Abstract
Summary: Background: Although topical retinoic acid effectively restores photoaged skin, the associated irritation limits the utility of the material. Retinaldehyde ( RAL ) is the natural precursor of retinoic acid and can also be used to treat photoaged skin; the safety profile is good. Aims: To evaluate the efficacy and safety of new anti‐aging creams containing RAL at 0.1% and 0.05% used to treat photoaged skin. Patients and methods: We enrolled 40 female Korean volunteers who applied RAL 0.1% or RAL 0.05% creams twice daily for 3 months. Wrinkles on, and the textures of, both crow's feet were quantitatively assessed using the Antera 3D ® system. Transepidermal water loss ( TEWL ), skin hydration, the melanin index, and skin brightness were also evaluated. Overall improvement was assessed using a five‐point scale by both the patients and the dermatologists. Results: The 3‐month application improved overall photoaging in both RAL 0.1% (95%) and RAL 0.05% groups (95%). Both RAL 0.1% and RAL 0.05% afforded significant textural improvements (13.7% and 12.6%, respectively), reduced the TEWL (14.5%, 17.9%), and increased hydration (10.2%, 6.0%); however, no statistical differences were observed between two groups. Only RAL 0.1% significantly improved the melanin index (by 6.5%). Conclusions: Both RAL 0.1% and RAL 0.05% creams were well tolerated and improved skin hydration and texture. However, only RAL 0.1% cream improved the melanin index.

This publication has 14 references indexed in Scilit: